Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.040
+0.030 (2.97%)
At close: Oct 7, 2026, 4:00 PM EDT
1.060
+0.020 (1.92%)
After-hours: Oct 7, 2026, 7:30 PM EDT
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $17.34 million as of October 7, 2026. That makes Marker Therapeutics the world's 38,185th most valuable company and 5,349th in the United States. Its market cap has increased by 23.86% in one year.
Market Cap
17.34M
Enterprise Value
6.01M
1-Year Change
23.86%
Global Rank
Country Rank
#5,349 United States
Category
ChartMarket Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $17.34M, a decrease of -62.14%. That is a compound annual growth rate of -9.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 17.30M | -30.24% |
| Dec 31, 2025 | 24.80M | -10.79% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 18.59M |
| TScan Therapeutics | 18.35M |
| Estrella Immunopharma | 17.96M |
| Palatin Technologies | 17.74M |
| Lipocine | 17.15M |
| NewcelX | 16.98M |
| Dyadic International | 16.55M |
| BioCardia | 16.12M |